2007. Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II. Biomolecules and Biomedicine. 7, 2 (May 2007), 113–118. DOI:https://doi.org/10.17305/bjbms.2007.3063.